Understanding Narrow‑Angle (Angle‑Closure) Glaucoma
Overview
Narrow‑angle glaucoma, also called angle‑closure glaucoma or primary angle‑closure glaucoma (PACG), is a type of glaucoma in which the drainage angle formed by the iris and cornea becomes too narrow or suddenly closes, preventing aqueous humor from exiting the eye. The resulting rapid rise in intra‑ocular pressure (IOP) can damage the optic nerve and lead to irreversible vision loss.
Who it affects
- Most common in people of Asian descent (particularly East Asian) – up to 20 % of glaucoma cases in these populations are angle‑closure.
- Women are affected 2–3 times more often than men.
- Typically occurs in middle‑aged to older adults, with a median age of diagnosis around 60 years.
Prevalence
- Globally, glaucoma affects ~76 million people; of those, about 5 % have angle‑closure disease (≈3.8 million).1
- In the United States, PACG accounts for roughly 10–15 % of all glaucoma cases.2
Symptoms
Symptoms may be chronic (gradual) or acute (sudden). Not all patients notice early warning signs, which is why regular eye exams are essential.
Acute (or “attack”) symptoms
- Severe eye pain – often described as a deep, throbbing ache.
- Sudden vision loss – blurred or hazy vision, sometimes with a rainbow‑like halo around lights.
- Headache – typically frontal or orbital.
- Nausea and vomiting – due to the rapid rise in IOP.
- Redness of the eye – conjunctival injection.
- Pupil dilation – the pupil may appear mid‑dilated and unresponsive to light.
Chronic (or “sub‑acute”) symptoms
- Gradual loss of peripheral (side) vision – patients may not notice until it is advanced.
- Mild eye discomfort or intermittent blurry vision.
- Often no pain; the disease can be “silent” until optic nerve damage is evident on testing.
Causes and Risk Factors
Angle‑closure glaucoma occurs when the anatomical angle between the iris and cornea becomes too narrow, limiting drainage through the trabecular meshwork.
Primary causes
- Anatomical predisposition – shallow anterior chamber depth, short axial length, or a thickened lens.
- Pupillary block – the flow of aqueous humor from the posterior to the anterior chamber is impeded, pushing the iris forward.
- Plateau iris configuration – an abnormal position of the ciliary body that crowds the angle.
Secondary causes
- Medications that dilate the pupil (e.g., antihistamines, anticholinergics, some antidepressants).
- Eye conditions such as uveitis, lens swelling (cataract), or neovascularization.
- Trauma or intra‑ocular surgery that changes anterior segment anatomy.
Risk factors
- Age > 40 years.
- Female sex.
- Asian or Inuit ancestry.
- Family history of angle‑closure glaucoma.
- Hyperopia (farsightedness) – associated with a shallower anterior chamber.
- High myopia is a risk for open‑angle glaucoma, not angle‑closure.
- Use of medications that provoke pupillary dilation.
Diagnosis
Diagnosis relies on a combination of clinical examination and specialized tests.
Key assessment steps
- Comprehensive eye exam – visual acuity, slit‑lamp biomicroscopy, and fundoscopy.
- Intra‑ocular pressure measurement – Goldmann applanation tonometry is the gold standard.
- – direct visualization of the drainage angle using a special contact lens; essential for confirming angle closure.
- Anterior segment imaging – anterior segment optical coherence tomography (AS‑OCT) or ultrasound biomicroscopy (UBM) to quantify angle width.
- Visual field testing – automated perimetry to detect functional vision loss.
- Optic nerve head assessment – fundus photography or OCT of the retinal nerve fiber layer (RNFL).
Acute attacks are diagnosed clinically based on symptoms, a markedly elevated IOP (often > 30 mm Hg), a mid‑dilated pupil, and a shallow anterior chamber on slit‑lamp examination.
Treatment Options
Management aims to lower IOP quickly in acute attacks and to prevent future episodes or chronic progression.
Acute angle‑closure attack
- Emergency topical medications – beta‑blockers (timolol), alpha‑agonists (brimonidine), prostaglandin analogues, and carbonic anhydrase inhibitors (dorzolamide) to reduce IOP.
- Systemic agents – oral carbonic anhydrase inhibitors (acetazolamide 500 mg) and hyperosmotic agents (mannitol 1–2 g/kg) if IOP remains high.
- Laser peripheral iridotomy (LPI) – creates a tiny opening in the peripheral iris to bypass the pupillary block; considered definitive treatment for most patients.
- Surgical intervention – if LPI fails or if there is concurrent lens-induced closure, lens extraction or peripheral iridectomy may be required.
Chronic or sub‑acute angle‑closure
- Laser iridotomy – first‑line prophylactic procedure.
- Laser peripheral iridoplasty – uses low‑energy laser spots to pull the peripheral iris away from the trabecular meshwork, widening the angle.
- Lens extraction (phacoemulsification) – especially in older patients with cataract; removes the bulky lens, deepening the anterior chamber.
- Medications – similar classes to those used in acute attacks, often at lower doses for long‑term IOP control.
Lifestyle and adjunct measures
- Avoid medications that dilate pupils unless absolutely necessary.
- Stay well‑hydrated; extreme dehydration can precipitate an attack.
- Limit activities that cause sudden changes in lighting (e.g., moving from bright outdoor light to a dark room).
Living with Narrow‑Angle Glaucoma
Managing the condition is a lifelong commitment, but many patients maintain good vision with proper care.
Daily management tips
- Adhere to medication schedule – use a pill/eye‑drop organizer and set alarms.
- Regular follow‑up appointments – at least every 3–6 months, or sooner if IOP fluctuates.
- Self‑monitor IOP (if available) – some practices loan portable tonometers for high‑risk patients.
- Protect eyes from trauma; wear safety glasses during sports or home repairs.
- Maintain a healthy weight and control systemic conditions such as hypertension and diabetes, which can affect ocular blood flow.
- Adopt a balanced diet rich in leafy greens, omega‑3 fatty acids, and antioxidants – nutrients associated with optic nerve health.
- Limit caffeine and alcohol intake, both of which may cause transient IOP spikes.
Emotional well‑being
Living with a chronic eye disease can be stressful. Consider joining a support group, counseling, or online communities (e.g., Glaucoma Support Network). Education empowers patients to recognize warning signs and stay proactive.
Prevention
While anatomical risk cannot be changed, several strategies can reduce the likelihood of an acute attack.
- Screening in high‑risk groups – early gonioscopy for Asians, hyperopic individuals, and those with a family history.
- Prophylactic laser iridotomy – recommended when a narrow angle is identified, even before symptoms appear.
- Review all medications with your ophthalmologist before starting new drugs that may dilate pupils.
- Maintain regular eye examinations (at least every 1–2 years for low‑risk adults; annually for high‑risk).
- Educate family members about the condition; early detection in relatives can be life‑saving.
Complications
If left untreated or inadequately controlled, narrow‑angle glaucoma can lead to:
- Irreversible optic nerve damage – resulting in permanent visual field loss.
- Blindness – usually begins with peripheral vision loss, eventually affecting central vision.
- Secondary glaucoma – due to scarring of the trabecular meshwork after repeated attacks.
- Vision‑related functional impairment – difficulty with driving, reading, or mobility, increasing fall risk.
- Psychological impact – anxiety, depression, or reduced quality of life.
When to Seek Emergency Care
- Sudden, severe eye pain that does not improve with rest.
- Rapidly worsening blurry vision or halos around lights.
- Redness of the eye accompanied by nausea or vomiting.
- A mid‑dilated pupil that does not react to light.
- Significant headache that started with eye symptoms.
References
- World Health Organization. Global data on visual impairments 2023. WHO; 2023.
- American Academy of Ophthalmology. Primary Angle‑Closure Glaucoma Preferred Practice Pattern. AAO; 2022.
- Mayo Clinic. “Angle‑closure glaucoma.” Updated 2024. https://www.mayoclinic.org
- Cleveland Clinic. “Narrow‑Angle Glaucoma.” 2023. https://my.clevelandclinic.org
- National Eye Institute (NEI). “Glaucoma Fact Sheet.” 2022. https://nei.nih.gov
- J. R. Wu et al., “Prevalence of Primary Angle‑Closure Glaucoma in Asian Populations,” *Ophthalmology*, vol. 130, no. 2, 2023, pp. 210‑219.